Committee conflicts
Trades and disclosed holdings where the politician sits on a committee whose jurisdiction overlaps the security's sector. Not an accusation of wrongdoing — STOCK Act trades are legal — but a structural conflict-of-interest signal worth noting.
Who owns what they regulate
Disclosed annual holdings in sectors the politician's committee or agency oversees, sorted by upper-bound disclosed value. Click any row to expand the per-position detail and source filing.
⚑ PharmaceuticalMerckMRKSenator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $250K – $500K⚑ PharmaceuticalAbbVieABBVSenator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $250K – $500K⚑ PharmaceuticalAmgenAMGNSenator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $250K – $500K⚑ PharmaceuticalNovartis AgNVSSenator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $100K – $250K
⚑ PharmaceuticalAbbVieABBVRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $50K – $100K⚑ PharmaceuticalAbbVieABBVRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $50K – $100K⚑ PharmaceuticalMerckMRKRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalJohnson & JohnsonJNJRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalJohnson & JohnsonJNJRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalMerckMRKRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalBristol-Myers SquibbBMYRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalBristol-Myers SquibbBMYRanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalPfizerPFERanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K⚑ PharmaceuticalPfizerPFERanking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K
⚑ PharmaceuticalEli LillyLLYChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $50K – $100K⚑ PharmaceuticalAmgenAMGNChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalAmgenAMGNChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalEli LillyLLYChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalAmgenAMGNChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalAmgenAMGNChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K⚑ PharmaceuticalNovartis AgNVSChair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K
⚑ PharmaceuticalJohnson & JohnsonJNJRepresentative on 4 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $100K – $250K
⚑ PharmaceuticalGilead SciencesGILDSenator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalAmgenAMGNSenator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalNovartis AgNVSSenator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalJazz Pharmaceuticals PLCJAZZSenator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalPfizerPFESenator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K
⚑ PharmaceuticalEli LillyLLYRepresentative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalBristol-Myers SquibbBMYRepresentative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K⚑ PharmaceuticalRegeneron PharmaceuticalsREGNRepresentative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K⚑ PharmaceuticalZoetisZTSRepresentative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K⚑ PharmaceuticalPfizerPFERepresentative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15K
⚑ PharmaceuticalJohnson & JohnsonJNJSenator on 3 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K⚑ PharmaceuticalJohnson & JohnsonJNJSenator on 3 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $15K – $50K
⚑ PharmaceuticalAbbVieABBVRepresentative on 2 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1K – $15KRRHHBY⚑ PharmaceuticalRepresentative on 2 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1 – $1K
⚑ PharmaceuticalCellectar BiosciencesCLRBRepresentative on 2 committees including Committee on Small Business holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1 – $1K⚑ PharmaceuticalCellectar BiosciencesCLRBRepresentative on 2 committees including Committee on Small Business holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector.Disclosed: $1 – $1K
John W. HickenlooperDSenate⚑ Pharmaceutical4 positions$850K – $1.8M

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $250K – $500K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $250K – $500K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $250K – $500K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Commerce, Science, and Transportation holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $100K – $250K | Senate EFD → |
Gary C. PetersDSenate⚑ Pharmaceutical10 positions$192K – $530K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $50K – $100K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $50K – $100K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | Senate EFD → | |
| ⚑ Pharmaceutical | Ranking Member, Committee on Appropriations on 4 committees including Committee on Appropriations holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | Senate EFD → |
Sheldon WhitehouseDSenate⚑ Pharmaceutical7 positions$112K – $330K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $50K – $100K | Senate EFD → | |
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | Senate EFD → | |
| ⚑ Pharmaceutical | Chair, Committee on Environment and Public Works on 6 committees including Committee on Environment and Public Works holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | Senate EFD → |
Lloyd DoggettDHouse⚑ Pharmaceutical1 position$100K – $250K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Representative on 4 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $100K – $250K | House Form A → |
Jacky RosenDSenate⚑ Pharmaceutical5 positions$75K – $250K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 4 committees including Committee on Armed Services holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → |
Greg LandsmanDHouse⚑ Pharmaceutical5 positions$19K – $110K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | House Form A → | |
| ⚑ Pharmaceutical | Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | House Form A → | |
| ⚑ Pharmaceutical | Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | House Form A → | |
| ⚑ Pharmaceutical | Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | House Form A → | |
| ⚑ Pharmaceutical | Representative on 4 committees including Committee on Energy and Commerce holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | House Form A → |
Tina SmithDSenate⚑ Pharmaceutical2 positions$30K – $100K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Senator on 3 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → | |
| ⚑ Pharmaceutical | Senator on 3 committees including Committee on Agriculture, Nutrition, and Forestry holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $15K – $50K | Senate EFD → |
Dwight EvansDHouse⚑ Pharmaceutical2 positions$1K – $16K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Representative on 2 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1K – $15K | House Form A → | |
R RHHBY | ⚑ Pharmaceutical | Representative on 2 committees including Committee on Ways and Means holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1 – $1K | House Form A → |
Morgan McGarveyDHouse⚑ Pharmaceutical2 positions$2 – $2K

| Holding | Sector | Why it's flagged | Disclosed band | Source |
|---|---|---|---|---|
| ⚑ Pharmaceutical | Representative on 2 committees including Committee on Small Business holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1 – $1K | House Form A → | |
| ⚑ Pharmaceutical | Representative on 2 committees including Committee on Small Business holds Pharmaceutical-sector security; this committee has substantive jurisdiction over this sector. | $1 – $1K | House Form A → |
Every flagged trade
Individual buy/sell disclosures from the STOCK Act periodic transaction reports, flagged where the trade's sector aligns with the politician's committee jurisdiction at the time it was filed.
- Filed May 1, 2026↓soldEli LillyLLYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern11trades in committee-overseen sectors
- Filed Apr 6, 2026↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Jan 2, 2026↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Oct 3, 2025↓soldAmgenAMGNCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Sep 11, 2025↓soldJohnson & JohnsonJNJCommitteeHealthSector⚑ PharmaceuticalPattern14trades in committee-overseen sectors
- Filed Jul 7, 2025↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Jul 2, 2025↓soldPfizerPFECommitteeCommittee on FinanceSector⚑ PharmaceuticalPattern9trades in committee-overseen sectors
- Filed Apr 17, 2025↓soldAbbVieABBVCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern10trades in committee-overseen sectors
- Filed Apr 11, 2025↓soldMerckMRKCommitteeHealthSector⚑ PharmaceuticalPattern14trades in committee-overseen sectors
- Filed Apr 8, 2025↓soldBristol-Myers SquibbBMYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Apr 7, 2025↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Feb 21, 2025↓soldEli LillyLLYCommitteeCommittee on FinanceSector⚑ PharmaceuticalPattern9trades in committee-overseen sectors
- Filed Feb 21, 2025↑boughtEli LillyLLYCommitteeCommittee on FinanceSector⚑ PharmaceuticalPattern9trades in committee-overseen sectors
- Filed Jan 8, 2025↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Dec 12, 2024↓soldEli LillyLLYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Nov 14, 2024↓soldPfizerPFECommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Nov 14, 2024↓soldRegeneron PharmaceuticalsREGNCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Nov 7, 2024↑boughtEli LillyLLYCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Oct 10, 2024↓soldAmgenAMGNCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Oct 10, 2024↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Aug 21, 2024↓soldJohnson & JohnsonJNJCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Aug 21, 2024↓soldJohnson & JohnsonJNJCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Aug 14, 2024↓soldEli LillyLLYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Aug 14, 2024↑boughtRegeneron PharmaceuticalsREGNCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Aug 14, 2024↑boughtEli LillyLLYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Aug 14, 2024↓soldEli LillyLLYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Aug 14, 2024↑boughtEli LillyLLYCommitteeCommittee on Energy and CommerceSector⚑ PharmaceuticalPattern137trades in committee-overseen sectors
- Filed Jul 3, 2024↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed May 20, 2024↓soldNovartis AgNVSCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Apr 9, 2024↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Jan 18, 2024↑boughtEli LillyLLYCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Jan 18, 2024↓soldPfizerPFECommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Jan 8, 2024↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Oct 17, 2023↑boughtEli LillyLLYCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Oct 17, 2023↑boughtNovartis AgNVSCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Oct 5, 2023↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Oct 3, 2023↔exchangedJohnson & JohnsonJNJCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Oct 3, 2023↔exchangedJohnson & JohnsonJNJCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern103trades in committee-overseen sectors
- Filed Jul 10, 2023↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Apr 10, 2023↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Jan 5, 2023↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldMerckMRKCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldRegeneron PharmaceuticalsREGNCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Dec 19, 2022↑boughtBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Nov 21, 2022↑boughtRRHHBYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern10trades in committee-overseen sectors
- Filed Nov 1, 2022↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Aug 19, 2022↑boughtAbbVieABBVCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern10trades in committee-overseen sectors
- Filed Jul 11, 2022↑boughtJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern51trades in committee-overseen sectors
- Filed Mar 3, 2022↓soldIntellia TherapeuticsNTLACommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Mar 3, 2022↓soldNovartis AgNVSCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Feb 1, 2022↑boughtNovartis AgNVSCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Nov 5, 2021↑boughtJazz Pharmaceuticals PLCJAZZCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Oct 30, 2021↓soldIntellia TherapeuticsNTLACommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Oct 5, 2021↓soldCrispr Therapeutics AgCRSPCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Oct 1, 2021↓soldIntellia TherapeuticsNTLACommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtCrispr Therapeutics AgCRSPCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldEli LillyLLYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldAstraZenecaAZNCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtAstraZenecaAZNCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldMerckMRKCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldEli LillyLLYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtEli LillyLLYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldCatalent, IncCTLTCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldPfizerPFECommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtBristol-Myers SquibbBMYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↓soldJohnson & JohnsonJNJCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtMerckMRKCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Sep 23, 2021↑boughtEli LillyLLYCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern117trades in committee-overseen sectors
- Filed Aug 7, 2021↓soldIntellia TherapeuticsNTLACommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Aug 7, 2021↑boughtRegeneron PharmaceuticalsREGNCommitteeCommittee on Ways and MeansSector⚑ PharmaceuticalPattern61trades in committee-overseen sectors
- Filed Jul 9, 2021↔exchangedMerckMRKCommitteeCommittee on Commerce, Science, and TransportationSector⚑ PharmaceuticalPattern106trades in committee-overseen sectors
| Filed | Politician | Trade | Committee | Sector | Conflict trades | Amount |
|---|---|---|---|---|---|---|
| May 1, 2026 | ![]() Lizzie Fletcher DHouse | ↓sold | Committee on Energy and Commerce | ⚑ Pharmaceutical | 11 | $8K |
| Apr 6, 2026 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Jan 2, 2026 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Oct 3, 2025 | ![]() Sheldon Whitehouse DSenate | ↓sold | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Sep 11, 2025 | ![]() Kelly Morrison DHouse | ↓sold | Health | ⚑ Pharmaceutical | 14 | $8K |
| Jul 7, 2025 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Jul 2, 2025 | ![]() Ron Wyden DSenate | ↓sold | Committee on Finance | ⚑ Pharmaceutical | 9 | $8K |
| Apr 17, 2025 | ![]() Dwight Evans DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 10 | $8K |
| Apr 11, 2025 | ![]() Kelly Morrison DHouse | ↓sold Stock (MRK) | Health | ⚑ Pharmaceutical | 14 | $8K |
| Apr 8, 2025 | ![]() Greg Landsman DHouse | ↓sold Common Stock (BMY) | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Apr 7, 2025 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Feb 21, 2025 | ![]() Ron Wyden DSenate | ↓sold | Committee on Finance | ⚑ Pharmaceutical | 9 | $75K |
| Feb 21, 2025 | ![]() Ron Wyden DSenate | ↑bought | Committee on Finance | ⚑ Pharmaceutical | 9 | $75K |
| Jan 8, 2025 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Dec 12, 2024 | ![]() Greg Landsman DHouse | ↓sold | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $32.5K |
| Nov 14, 2024 | ![]() Greg Landsman DHouse | ↓sold | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $32.5K |
| Nov 14, 2024 | ![]() Greg Landsman DHouse | ↓sold Common Stock (REGN) | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Nov 7, 2024 | ![]() Sheldon Whitehouse DSenate | ↑bought | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $32.5K |
| Oct 10, 2024 | ![]() Sheldon Whitehouse DSenate | ↓sold | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Oct 10, 2024 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Aug 21, 2024 | ![]() Sheldon Whitehouse DSenate | ↓sold | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $32.5K |
| Aug 21, 2024 | ![]() Sheldon Whitehouse DSenate | ↓sold | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $32.5K |
| Aug 14, 2024 | ![]() Greg Landsman DHouse | ↓sold | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Aug 14, 2024 | ![]() Greg Landsman DHouse | ↑bought Common Stock (REGN) | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Aug 14, 2024 | ![]() Greg Landsman DHouse | ↑bought | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Aug 14, 2024 | ![]() Greg Landsman DHouse | ↓sold | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Aug 14, 2024 | ![]() Greg Landsman DHouse | ↑bought | Committee on Energy and Commerce | ⚑ Pharmaceutical | 137 | $8K |
| Jul 3, 2024 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| May 20, 2024 | ![]() Sheldon Whitehouse DSenate | ↓sold | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Apr 9, 2024 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Jan 18, 2024 | ![]() Sheldon Whitehouse DSenate | ↑bought | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Jan 18, 2024 | ![]() Sheldon Whitehouse DSenate | ↓sold | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Jan 8, 2024 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Oct 17, 2023 | ![]() Sheldon Whitehouse DSenate | ↑bought | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $32.5K |
| Oct 17, 2023 | ![]() Sheldon Whitehouse DSenate | ↑bought | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $32.5K |
| Oct 5, 2023 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Oct 3, 2023 | ![]() Sheldon Whitehouse DSenate | ↔exchanged | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Oct 3, 2023 | ![]() Sheldon Whitehouse DSenate | ↔exchanged | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 103 | $8K |
| Jul 10, 2023 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Apr 10, 2023 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Jan 5, 2023 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold 2000084729 Bristol-Myers Squibb Company (BMY) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold 2000084726 Bristol-Myers Squibb Company (BMY) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold 2000084548 Bristol-Myers Squibb Company (BMY) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↑bought 2000084479 Johnson & Johnson (JNJ) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold Stock (MRK) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold 2000084402 Bristol-Myers Squibb Company (BMY) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Dec 19, 2022 | ![]() Thomas R. Suozzi DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Nov 21, 2022 | ![]() Dwight Evans DHouse | ↑bought R RHHBYDepositary Shares (RHHBY) | Committee on Ways and Means | ⚑ Pharmaceutical | 10 | $8K |
| Nov 1, 2022 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Aug 19, 2022 | ![]() Dwight Evans DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 10 | $8K |
| Jul 11, 2022 | ![]() Lloyd Doggett DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 51 | $8K |
| Mar 3, 2022 | ![]() Donald S. Beyer Jr. DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $32.5K |
| Mar 3, 2022 | ![]() Donald S. Beyer Jr. DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $32.5K |
| Feb 1, 2022 | ![]() Donald S. Beyer Jr. DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $8K |
| Nov 5, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought Ordinary Shares (JAZZ) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Oct 30, 2021 | ![]() Donald S. Beyer Jr. DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $8K |
| Oct 5, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold Common Shares (CRSP) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $75K |
| Oct 1, 2021 | ![]() Donald S. Beyer Jr. DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought Common Shares (CRSP) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $75K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold Depositary Shares (AZN) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $75K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought Depositary Shares (AZN) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold Stock (MRK) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought Stock (MRK) | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $32.5K |
| Sep 23, 2021 | ![]() Thomas R. Suozzi DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 117 | $8K |
| Aug 7, 2021 | ![]() Donald S. Beyer Jr. DHouse | ↓sold | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $8K |
| Aug 7, 2021 | ![]() Donald S. Beyer Jr. DHouse | ↑bought | Committee on Ways and Means | ⚑ Pharmaceutical | 61 | $8K |
| Jul 9, 2021 | ![]() John W. Hickenlooper DSenate | ↔exchanged | Committee on Commerce, Science, and Transportation | ⚑ Pharmaceutical | 106 | $8K |
Conflict flags are computed automatically by matching each politician's active committee assignments against the GICS sector of every ticker they trade or hold. A flag is a structural signal, not an accusation: STOCK Act trades are legal and Annual financial disclosures are required by law. Read the full methodology.





